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Introduction
An intriguing biomarker termed Ischemia-Modified Albumin (IMA) has been attracting much attention in recent years. [1] [2] [3] [4] IMA, as measured by the Albumin-Cobalt-Binding assay (ACB assay 5 ) , is the only FDAapproved early biomarker for myocardial ischemia, 3 a contributing factor to acute coronary syndrome that may lead on to a heart attack. Plasma from ischemic patients displays reduced Co 2+ -binding ability compared to healthy controls; 6 this can be detected colorimetrically via complex formation between Co 2+ and dithiothreitol (DTT). However, whilst the ACB assay has been found to have a high negative prognostic value 6, 7 and helps to exclude ischemia as a cause of chest pain, its specificity is low. 3, 8 Accordingly, increased IMA values have been detected in a plethora of other conditions including fatty liver, cancer, infections, renal disease, preeclampsia, diabetes, stroke, and even sustained exercise. [2] [3] [4] [8] [9] [10] Hence, several recent studies have questioned the usefulness of the ACB assay. 11, 12 Despite over 70 studies involving over 15,000 patients, no conclusive explanation for the performance characteristics of the ACB assay has been offered, hampering efforts to improve its prognostic and/or diagnostic value. Most strikingly, perusal of IMA-related literature reveals that the actual identity of this biomarker is unclear. "IMA" has so far only been defined in terms of its decreased Co-binding capacity, but the actual nature of the putative ischemia-induced modifications has remained elusive. Identifying these modifications is important as it would not only provide an insight into the mechanism involved in the formation of IMA, and help to understand how and why IMA correlates with certain diseases, but also aid understanding of the chemical basis for the ACB assay, which might lead to improvements in its performance.
Most efforts to understand the mechanism of action of the ACB assay have centred on the N-terminus of albumin, 5, 13, 14 which has been assumed to be the main Co 2+ binding site. Following the failure to demonstrate a correlation between N-terminal modifications and IMA, more recent suggestions have included lower plasma pH (acidosis) and altered redox balance, 5, 14 and although changes in these conditions are plausible as factors influencing the speciation of Co 2+ during the ACB assay, their impact has not been verified experimentally.
Another intriguing link between ischemic conditions and the Co-binding capacity of plasma has emerged recently. In 2008, a relationship between fatty acids and IMA levels was suggested. 9 It is known that the plasma concentration of "free" fatty acids (FFA) is increased during myocardial ischemia. 4, 15 Indeed, serum fatty acids may themselves serve as a marker of myocardial injury. 2, 16 Crucially, so-called FFA are not free, but predominantly bound to serum albumin (Fig. 1) Faller. 20 Solutions for ITC were carefully degassed, and no further exposure to air occurred during the titrations.
It was noted that the first few additions produced large exothermic peaks even in the absence of albumin; it is conceivable that this may have been due to either residual oxygen or Co 3+ in the reaction vessel, and these titration points were discarded. (ii) an hysteretic effect for Co 2+ binding to albumin has been noted previously.
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Care was taken that there was no residual heat evolution before each subsequent addition of Co 2+ . With these precautions in place, consistent data were obtained. Under the conditions employed, the binding reaction of Co 2+ with BSA was exothermic (Supplementary Figure S1 ). Apparent binding constants for Co 2+ binding to BSA (log K app(Co-BSA) ) were ca. one order of magnitude lower than that determined previously for the highest affinity Zn 2+ site, 19 irrespective of the binding model chosen. The ITC data can be fitted well with a simple model of one set of binding sites; these fits converged robustly, and gave an average log K app(Co-BSA) = 4.6 ± 0.3, together with a binding site stoichiometry of 2.4 ± 0.4. This log K value lies between the reported values (4.9, 4.0, and 3.9) for individual binding sites in HSA. 30 At this point, it should be noted that a difference of less than 1 log unit means that the binding equilibria for the various sites will substantially overlap, rendering resolution of individual constants difficult. Furthermore, the overall low binding constants also mean that significant amounts of Co 2+ will remain unbound to albumin during the titrations, as well as in the ACB test, since only 25 μM BSA was employed in our work, and ca. 90-100 μM HSA is present in the final ACB assay solutions. For example, it can be calculated from the published equilibrium constants 30 that under typical ACB test conditions 6 but in the absence of DTT, 46% of Co will be bound to the primary site, and about 16% to each of the other two sites, with 22% remaining unbound or bound to other plasma components. Unfortunately, the theoretical distribution in the presence of DTT cannot be calculated because no log K values for the Co-DTT system are available due to precipitation of the complexes formed. 34 Having established the behaviour of the binary system, competition with other metals was studied. The N- Binding of a fatty acid molecule to the interdomain site FA2 (Figure 1 ) changes the mutual orientation of domains I and II, and separates the four residues (His67, Asn99 from domain I, and His247 and Asp249 from domain II) forming the Zn-binding site. 19, 40, 24, 26 The effect on site B (primary site for Cd and secondary site for Zn) had been unexpected, but suggested that its structure is also dependent on fatty acid loading.
In the light of these findings, the influence of fatty acid loading on Co 2+ binding was studied, employing ITC experiments for Co 2+ titrated with BSA in the absence and presence of bound myristate (1-5 mol equiv).
Myristate was chosen as its albumin binding characteristics are similar to those of the most common physiological fatty acids, stearate and oleate (C16 and C18), and because of its higher solubility in aqueous solution which was sufficient to fulfil the requirements for ITC experiments. The titration data reveal that overall, Figure S2 ).
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The findings from both competition experiments confirm conclusively that myristate and Co 2+ binding are interactive, and that fatty acids decrease the Co 2+ -binding capacity of albumin -but does this provide the molecular basis for the ACB assay? To test whether fatty acids alone impact sufficiently on the results of the ACB assay to explain observed differences between normal and ischemic conditions, solutions containing 600 that a difference of 0.2 absorbance units, a typical difference observed between healthy and ischemic patients, corresponds to slightly less than 3 fatty acid molecules per albumin molecule, a value that is in line with observed differences in expected fatty acid loading under normal and ischemic conditions.
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Conclusions
In summary, the results presented here, together with the knowledge that ischemia leads to increased plasma fatty acid levels. 4, 16, 36, 37 suggest that the enigmatic modifications that define IMA correspond mainly to an increase in the number of fatty acid molecules bound to otherwise normal albumin, although contributions from acidosis or disturbed redox balance as suggested by others 14 cannot be excluded as further contributing factors and require further study. This would mean that "IMA" is strictly speaking neither a marker for ischemia nor oxidative stress, but a proxy for FFA levels. This conclusion can explain virtually all clinical observations. For example, the rapid return to normal IMA values within hours of the ischemic injury is hard to reconcile with any changes to covalent bonds including bond cleavage or oxidative damage, given the large half-life of albumin (19 days), but is fully consistent with expected fluctuations in FFA levels. This allosteric link can also rationalize the low specificity of the ACB test, as any condition that leads to raised FFA levels would also raise the levels of IMA. Such conditions include obesity, diabetes, demanding aerobic physical exercise, prolonged fasting, and indeed other types of ischemia -a compilation that parallels the list of conditions in which elevated levels of IMA have been observed. 3, 4, 9, 10 Interestingly, the characteristics of a nickel-albumin binding assay were described recently. 38 The primary 23 and under the test conditions, which involve an excess of Ni 2+ over albumin, the fatty-acid-sensitive site A will play a significant role in overall binding.
In terms of improving the prognostic value of IMA, we propose that the ACB assay could be optimized to
give an alternative rapid and cost-effective measurement for the FFA/albumin ratio. Besides their potential diagnostic utility in acute coronary syndrome, FFAs have recently been identified as useful prognostic markers that are strongly correlated with mortality in stable coronary heart disease, 39 and are also important clinical markers for metabolic syndrome.
Experimental Section
Sample preparation. For all experiments, BSA (Sigma, essentially fatty acid free and essentially globulin free) was extensively dialyzed against the desired buffer to remove metal ions and other low-molecular weight impurities. 40 Concentrations were determined using a molar absorptivity of 43,824 M -1 cm -1 at 280 nm. Cd NMR and ACB experiments were prepared by adding carefully measured amounts of the competing agent to BSA, followed by incubation for 2 h at 310 K. In the case of Cu 2+ , 22 quantitative formation of the complexes can be assumed, whereas the Zn 2+ , Cd 2+ , Co 2+ , and myristate complexes are weaker, and will form to a lesser extent. All added metal ions and fatty acids will however participate in the competition reactions. fitted with a BBO probe-head and operating at 106.037 MHz for 111 Cd. Inverse-gated decoupling during acquisition was achieved using a GARP sequence. Spectra were referenced to an external standard of 0.1 M Cd(ClO 2 ) 4 . Data were acquired with 8k complex data points and a spectral width of 300 ppm at 310 K. The data were zero-filled to 32k data points, apodized by exponential multiplication using a line-broadening factor of 90 Hz, and Fourier transformed. Data processing and analysis were carried out using the TOPSPIN 2.1 software package (Bruker BioSpin). 
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